Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
22.18 SEK | +0.11% | +55.38% | -3.93% |
04-25 | Transcript : Sedana Medical AB, Q1 2024 Earnings Call, Apr 25, 2024 | |
04-25 | Sedana Medical AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Sales 2024 * | 188M 17.43M 23.76M | Sales 2025 * | 239M 22.24M 30.32M | Capitalization | 2.2B 204M 279M |
---|---|---|---|---|---|
Net income 2024 * | -53M -4.92M -6.71M | Net income 2025 * | -42M -3.9M -5.32M | EV / Sales 2024 * | 10.5 x |
Net cash position 2024 * | 223M 20.71M 28.24M | Net cash position 2025 * | 94.2M 8.75M 11.93M | EV / Sales 2025 * | 8.79 x |
P/E ratio 2024 * |
-42.1
x | P/E ratio 2025 * |
-50.7
x | Employees | 79 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 63.5% |
Latest transcript on Sedana Medical AB
1 day | +0.11% | ||
1 week | +55.38% | ||
Current month | +38.98% | ||
1 month | +42.63% | ||
3 months | +5.15% | ||
6 months | +9.71% | ||
Current year | -3.93% |
Managers | Title | Age | Since |
---|---|---|---|
Johannes Doll
CEO | Chief Executive Officer | 43 | 21-09-30 |
Johan Spetz
DFI | Director of Finance/CFO | - | 22-04-03 |
Peter Fröberg
CTO | Chief Tech/Sci/R&D Officer | 53 | 20-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hilde Furberg
BRD | Director/Board Member | 65 | 21-12-31 |
Director/Board Member | 49 | 20-05-18 | |
Claus Bjerre
CHM | Chairman | 53 | 21-05-09 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-03 | 22.25 | +0.45% | 155 021 |
24-05-02 | 22.15 | -2.21% | 323,833 |
24-04-30 | 22.65 | +7.35% | 188,696 |
24-04-29 | 21.1 | +2.18% | 249,392 |
24-04-26 | 20.65 | +9.14% | 502,248 |
Delayed Quote Nasdaq Stockholm, May 03, 2024 at 09:17 am
More quotesEPS Revisions
- Stock Market
- Equities
- SEDANA Stock